Biotricity, Inc. (BTCY) Financials
BTCY Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 6.4 million | 39.4 million |
| Dec. 31, 2025 | 5.7 million | 38.2 million |
| Sept. 30, 2025 | 6.3 million | 38.0 million |
| June 30, 2025 | 6.0 million | 36.8 million |
BTCY Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -20905 | 7695 |
| Dec. 31, 2025 | -740291 | 6001 |
| Sept. 30, 2025 | 415630 | 6001 |
| June 30, 2025 | -373389 | 5935 |
BTCY Net Income
No data available :(
BTCY Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 149789 | 870800 | 397830 |
| Dec. 31, 2025 | 256357 | 13.0 million | 539398 |
| Sept. 30, 2025 | 308460 | 12.9 million | 674013 |
| June 30, 2025 | 391292 | 13.3 million | 803380 |
BTCY Shares Outstanding
BTCY Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 5 | 841669 | 1.9 million | - |
| Dec. 31, 2025 | - | 623567 | 2.2 million | - |
| Sept. 30, 2025 | - | 602798 | 2.3 million | - |
| June 30, 2025 | - | 696163 | 2.1 million | - |
BTCY Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 4.3 million | 851608 |
| Dec. 31, 2025 | 4.0 million | 736343 |
| Sept. 30, 2025 | 3.9 million | 704297 |
| June 30, 2025 | 3.9 million | 757193 |
BTCY Revenue by Segment
Graph available only for paid members. Upgrade to see it.
BTCY
Price: $0.11
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.16 USD
P/E Ratio: -1.87
Exchange: OQB
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 195900
Market Capitalization: 4.0 million